Bajaj Healthcare Share Price

Bajaj Healthcare

CMP as on 20-May-22 15:41

₹ 326.65
-2.00 -0.61%

Open

₹ 332.00

Turnover (lac)

₹ 113

Prev. Close

₹ 328.65

Day's Vol (shares)

₹ 34,461

Day's Range (₹)

₹ 317.00
₹ 333.00

CMP as on20-May-22 15:41

₹ 325.05
-3 -0.91%

Open

₹ 338.00

Turnover (lac)

₹ 42

Prev. Close

₹ 328.05

Day's Vol (shares)

₹ 4,730

Day's Range

₹ 318.00
₹ 338.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 10-May-2022 - -
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2022 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 17th May 2022 inter alia to: -Consider and approve Audited Financial Result for the quarter / year ended March 31 2022. -Recommend final dividend on equity shares if any for the financial year ended March 31 2022. -Any other matter with the permission of the Chair. You are requested to take the same on record. We hereby inform you that at the meeting of the Board of Directors of our Company held today i.e. 17th May, 2022 has considered and approved the following: - The Board of Directors have recommended a final dividend of 30% i.e. Rs.1.50/- per equity shares on face value of Rs.5/- each for the financial year ended 31st March, 2022, subject to approval of shareholders in the ensuing Annual General Meeting. (As Per BSE Announcement Dated on 17.05.2022)
Board Meeting - 21-Jan-2022 - -
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 28th January 2022 inter alia to consider and approve: Unaudited Financial Result for the quarter / nine months ended December 31 2021. Any other matter with the permission of the Chair. You are requested to take the same on record. Outcome of Board meeting and submission of financial result for the Quarter and nine months ended 31st December, 2021 (As Per BSE Announcement dated on 28.01.2022)
Board Meeting - 25-Oct-2021 - -
Quarterly Results The Board of Directors at its Meeting held today has inter alia: -Approved the unaudited Financial Statements for the quarter / half year ended September 30, 2021, as recommended by the Audit Committee We wish to inform you that Board Meeting commenced today at 04.00 p.m. and concluded at 5.25 p.m. Kindly take the same on record. The Board of Directors at its Meeting held today has inter alia: -Approved the unaudited Financial Statements for the quarter / half year ended September 30, 2021, as recommended by the Audit Committee; We wish to inform you that Board Meeting commenced today at 04.00 p.m. and concluded at 5.25 p.m. Kindly take the same on record. (As Per BSE Announcement Dated 02.11.2021)
Board Meeting - 27-Jul-2021 - -
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 13th August, 2021, inter alia, to consider and approve: -Sub-division/ Stock Split of equity shares of the Company. -Any other matter with the permission of the Chair. You are requested to take the same on record. Pursuant to Regulation 29 (3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, 13th August, 2021, inter alia, to consider and approve: -Sub-division/ Stock Split of equity shares of the Company. -Any other matter with the permission of the Chair. You are requested to take the same on record. (As Per BSE Announcement Dated on 28.07.2021) The Board of Directors at its Meeting held today has inter alia: Recommended the proposal for sub-division of Companys One (1) equity share of face value of Rs 10/- each into Two (2) equity shares of face value of Rs.05/- each, subject to the shareholders and other approvals as may be required. Recommended alteration of Capital Clause (Clause V) in the Memorandum of Association of the Company, subject to the approval of shareholders: The details as required under Regulation 30 of SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9 September, 2015, (SEBI Circular) have been enclosed herewith as Annexure -I for sub-division and alteration of capital cause of Memorandum of Association. (As Per BSE Announcement dated on 13.08.2021)
Board Meeting - 26-Jul-2021 - -
Quarterly Results Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 03rd August, 2021, inter alia, to consider and approve: Unaudited Financial Result for the quarter ended June 30, 2021. Any other matter with the permission of the Chair. You are requested to take the same on record. The Board of Directors at its Meeting held today has inter alia: Approved the unaudited Financial Statements for the quarter ended June 30, 2021, as recommended by the Audit Committee; Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure requirements) Regulations, 2015, we enclose the following: (i) Unaudited Financial Results for the quarter ended June 30,, 2021 along with limited review report; and We wish to inform you that Board Meeting commenced today at 01.00 p.m. and concluded at 3.45 p.m. (As Per BSE Announcement dated on 03.08.2021)
Board Meeting - 05-Jul-2021 - -
We hereby inform you that at the meeting of the Board of Directors of our Company held today, the Board has considered and approved the listing of 1,37,99,200 (One Crore Thirty Seven Lakh Ninety Nine Thousand Two Hundred) equity shares of Rs.10/- (Rupees Ten) each of the Company on National Stock Exchange of India (NSE).
Board Meeting - 01-Jun-2021 - -
Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2021 ,inter alia, to consider and approve This is to inform you that, Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 9th June, 2021, inter alia, to consider and approve: 1) Audited Financial Result for the quarter / year ended March 31, 2021. 2)To consider and recommend final dividend on equity shares, if any, for the financial year ended March 31, 2021. 3)Any other matter with the permission of the Chair. You are requested to take the same on record. Recommended payment of final dividend of Re. 0.50/- and special dividend of Re. 0.50/- per equity share of Rs 10/- each for the year ended March 31, 2021, subject to approval of the Shareholders at the ensuing Annual General Meeting The Company has already declared and paid interim dividends of 12.50% ( Rs.1.25 /-) each per share of Rs. 10/- each for the financial year ended 31st March,2021. The total dividend for the financial year ended 31st March 2021(including the special dividend) works out to 27.50% (Rs. 2.75/-) per share of Rs.10 each Outcome of Board Meeting (As Per BSE Announcement Dated on 09.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity